Source comparison
GHRP-2 Acetate vs Hexarelin — Peptide Comparison
Hexarelin is the most potent growth hormone secretagogue available. Until it stops working. Research published in the Journal of Clinical Endocrinology & Metabolism found that Hexarelin-induced GH secretion drops by as much as 50% after just 14 consecutive day
This comparison does not assign a generated winner or score.
- Hexarelin is the most potent growth hormone secretagogue available. Until it stops working. Research published in the Journal of Clinical Endocrinology & Metabolism found that Hexarelin-induced GH secretion drops by as much as 50% after just 14 consecutive days of administration, a desensitization rate significantly faster than GHRP-2 Acetate. That difference matters when you're designing multi-week protocols.
- We've supplied both peptides to hundreds of research institutions. The gap between doing it right and doing it wrong comes down to understanding mechanism, potency curves, and when rapid desensitization turns a promising compound into an expensive control variable.
- What is the difference between GHRP-2 Acetate and Hexarelin?
- GHRP-2 Acetate and Hexarelin are both growth hormone-releasing peptides (GHRPs) that bind to ghrelin receptors, but Hexarelin produces stronger GH secretion (up to 2x higher peak levels in some models) while also elevating cortisol and prolactin more aggressively. GHRP-2 Acetate exhibits milder receptor desensitization, making it better suited for sustained multi-week studies, whereas Hexarelin's potency peaks early but tapers faster.
- Yes, GHRP-2 Acetate vs Hexarelin is a meaningful distinction. Not just a brand choice. The same dose of Hexarelin can produce GH pulses 1.5–2x higher than GHRP-2 Acetate during the first week of administration, but that advantage erodes rapidly as ghrelin receptor sensitivity declines. Meanwhile, GHRP-2 Acetate maintains more consistent secretion across weeks 2–6, though at lower peak amplitude. The choice depends on whether your research prioritizes acute maximal GH release or sustained elevation over time. This piece covers receptor pharmacology, dosing kinetics, side effect profiles, and protocol design strategies for both peptides.